Synopsis: The share of this defence and precision engineering company has delivered close to 400 percent returns in one year, supported by Rs 2,580 crore order book and upgraded FY27 growth guidance driven by clean energy and defence demand. India’s defence...
Synopsis: Stocks of these eight companies touched their upper circuits of 20 percent, suggesting high buying interest and drawing the interest of the investors and traders. Upper circuit stocks normally indicate high buying interest and good market sentiment in a...
Summary: These companies have a strong cash position of up to Rs 46,196.79 crore, little or no debt, and healthy return ratios. You can see that in the financials and the smart use of capital, so they can weather volatility and keep growing. There are plenty of firms...
Synopsis: FTC-approved $250 million deal is set to support US growth, add new complex medicines, improve manufacturing capacity, and help increase earnings through better scale and efficiency over time. The article outlines the importance of the deal for this pharma...
Synopsis: The brokerage firm assigns the pharma stock a ‘Buy’ recommendation, which suggests that there is an upside of about 26 percent, driven by solid pipeline performance, clear growth visibility, and a $214 million market potential from its new US...
Synopsis: The healthcare stocks jumped nearly 7% on the news that there could be up to 10% selling of promoter stakes, which attracted investors due to the anticipated institutional involvement. The share of this company, which operates across both Human and Animal...
Synopsis: There have been quite a few stocks that witnessed an increase to 20 percent upper circuit during the course of the day on account of high buying pressure in particular sectors like manufacturing, chemical, IT service, logistic, and infrastructure. The Indian...
Synopsis: Shares of six companies from the fintech, marine infrastructure, steel, apparel, technology, and renewable energy sectors remained in focus after block and bulk deals worth over Rs 414 crore were executed on the exchanges. Indian equity markets are likely to...
Synopsis: The share of this pharmaceutical company remains supported by strong growth guidance, improving global business momentum, and a Rs 19,000 crore AbbVie deal that could unlock long-term value from its innovation pipeline. The article outlines the significance...
Synopsis: Alcohol stocks surged up to 5 percent on improved sector sentiment, stronger demand expectations, and better margin visibility, boosting investor interest in consumption-led discretionary stocks. Alcohol stocks gained today in trade as broader optimism...
